SCHEMBL14050570

SCHEMBL14050570

Cc1cc(Nc2cc(C3CC3)[nH]n2)nc(NCC2CC(C3CCCCC3)=NO2)n1

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 20/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14050425 0.82 IGF1R (0.56) IGF1R
SCHEMBL14162125 0.81 IGF1R (0.64) IGF1R
SCHEMBL12439843 0.79 IGF1R (0.64) IGF1R
SCHEMBL14162068 0.79 IGF1R (0.65) IGF1R
SCHEMBL12439435 0.79 IGF1R (0.55) IGF1R
SCHEMBL14050670 0.79 IGF1R (0.66) IGF1R
SCHEMBL3926180 0.76 IGF1R (1.00) IGF1R
SCHEMBL4015754 0.73 IGF1R (1.00) IGF1R
SCHEMBL12438466 0.72 IGF1R (0.68) IGF1R
SCHEMBL14161872 0.72 IGF1R (0.63) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008124161-A1 METHODS OF TREATING CANCER USING PYRIDOPYRIMIDINONE INHIBITORS OF PI3K ALPHA EXELIXIS, INC. (US) 2008-10-16 WO disclosed